Loading clinical trials...
Loading clinical trials...
Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and C Hepatitis Who Failed to Active Treatment for HCV. ANRSHC12 Fibrostop
Conditions
Interventions
Peginterferon alpha-2a (Pegasys®)
Ribavirin
+2 more
Locations
1
France
Service de Maladies Infectieuses et de Réanimation Médicale
Rennes, France
Start Date
November 1, 2003
Primary Completion Date
March 1, 2009
Completion Date
March 1, 2009
Last Updated
February 22, 2012
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions